During a presentation at the American Academy of Ophthalmology’s 2020 virtual annual meeting, Kathleeen B. Digre, MD, details how a headache in conjunction with visual loss is a scenario that requires an in-depth examination, including evaluation of the visual fields, pupils, and fundus to gather clues to the diagnosis.
Glenn J. Jaffe, MD, presents a summary of the results of a confirmatory study on a previous Phase III trial that examined sustained drug delivery for the treatment of uveitis, as well as data on the 36-month results in the second, confirmatory phase 3 study of YUTIQ.
Ram Liebenthal, U.S. general manager for Heidelberg Engineering, discusses how the company continues to invest in the Spectralis platform in terms of hardware and software improvements.
Josh Anderson, head of U.S. retina sales and marketing for Alcon, outlines what attendees will learn including product updates, new technologies, and practice management materials for ophthalmologists and their patients during the COVID-19 pandemic.
Ted Leng, MD, MS, Byers Eye Institute at Stanford, and medical advisor for Verana Health, talks about data insights for retinal surgeons. Steven D. Schwartz, MD, Stein Eye Institute, UCLA, highlights his AAO presentation, “New Insight into Real-World U.S. Injection Data."
During Day 1 of AAO 2020, Carl Awh, MD, discusses the Micro-Vacuum Pick, a device for peeling internal limiting membranes that's providing vitreoretinal surgeons an alternative to forceps during surgeries.
At AAO 2020, Fernando Arevalo, MD, PhD, details the use of anti-VEGF therapy for the treatment of retinal arteriolar macroaneurysms that are near the fovea.
Chris Brittain, MBBS, BSc, MBA, MRCOphth, vice president and global head of ophthalmology product development for Genentech, provides an overview of the company’s podium presentations from the PDS with ranibizumab to faricimab.
Prof. Marie-José Tassignon, past chief and chair, Department of Ophthalmology, Antwerp University and University Hospital Antwerp, Belgium, expands on her upcoming AAO presentation by providing an overview of her novel technique in performing a risk-free posterior capsulorhexis.
Anne L. Coleman, MD, president of the American Academy of Ophthalmology, offers a preview of its virtual 2020 annual meeting. The AAO is rising to meet the challenges of staging a large-scale event in a virtual setting.
The Ophthalmology Times Resident Writers Award Program is a competitive writing program showcasing the best case studies in anterior segment.
Algorithm detects, stratifies severity of disease, facilitates early diagnosis.
The curators of the American Academy of Ophthalmology’s (AAO) Truhlsen-Marmor Museum of the Eye have been toiling diligently despite the COVID-19 pandemic. So, when opening day does arrive, the results will be eye-opening.
The eye health community is sounding the alarm that the COVID-19 pandemic could worsen the epidemic of children at risk of nearsightedness.
DME diagnosis plays no role in determining whether patients will receive injection.
A Phase 3 clinical trial of NCX 470 will evaluate the drug for the lowering of IOP in patients with open-angle glaucoma or ocular hypertension.
Elevated pressure can lead to irreversible optic nerve damage, vision loss
Pfizer Inc. and BioNTech SE this week announced their mRNA-based coronavirus vaccine candidate has demonstrated evidence of efficacy against COVID-19 in participants without evidence of infection.
The University of California San Francisco this week debuted the UCSF Wayne and Gladys Valley Center for Vision, bringing its vision care and research facilities under one roof.
Optics block out-of-focus and stray light, allow continuum of vision.
Device allows visually impaired to recognize shapes, distinguish between light and dark.
Research could lead to a novel therapeutic strategy for blinding disease
The program is dedicated to the education of fellows and residents and offers a unique opportunity to share notable retina research with peers and mentors.
Study examines use of fluocinolone acetonide for treating DME in patients.
Cutting-edge solutions are emerging in healthcare that streamline data capture through a user-friendly interface, leading to an increase in quality and accuracy of data collection while freeing physicians to spend more time with patients.
Study shows improvements in signs, symptoms after 3 months of treatment
New paradigm-changing treatments for young patients on the horizon.
Check out the latest cartoon!
Interest stems from the recognition that the number of people affected with cataracts is expected to increase in association with population aging while access to cataract surgery is limited in areas throughout the world.
Investigators suggest incorporating an examination for mites as part of the preoperative evaluation.
